RESTORATION OF AN EARLY, PROGRESSIVE DEFECT IN RESPONSIVENESS TO T-CELL ACTIVATION IN LUPUS MICE BY EXOGENOUS IL-2

被引:15
作者
HUANG, FP
STOTT, DI
机构
[1] Department of Immunology, University of Glasgow, Western Infirmary, Glasgow
关键词
CON-A; IL-2; IL-2R; NZB/W; MRL LPR; SLE;
D O I
10.3109/08916939309004835
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Splenic T-cells from lupus strain (NZB/W F1, Mrl/lpr) mice lack the ability to respond to concanavalin A (Con A) by secretion of IL-2 and hence expression of IL-2 receptor and proliferation. These defects were found not only in an aged group (>5 months) of mice in which obvious clinical 'SLE like' symptoms and elevated levels of serum autoantibodies were observed, but also in mice as young as 4-wk. We demonstrate here that the defective mitogenic activation of T-cells from lupus mice is due to the inability of T-helper cells to produce IL-2 and this defect can be restored by exogenous IL-2 in vitro. Con A-induced cell proliferation and IL-2 receptor expression on CD3+ cells from lupus mice occur only in the presence of exogenous IL-2, whereas normal T-cells from BALB/c and CBA control mice are activated by the mitogen and undergo complete cell cycling in the absence of exogenous IL-2, as they are able to secrete sufficient endogenous IL-2. The detection of impaired T-helper function in young lupus mice, before development of overt disease, and the reversible nature of the defect indicate that defective IL-2 activity may be fundamental to the mechanism of development of pathology in SLE.
引用
收藏
页码:19 / 29
页数:11
相关论文
共 27 条
[1]  
Balkwill F.R., Burke F., The cytokine network, Immunology Today, 10, pp. 299-304, (1989)
[2]  
Kroemer G., Wick G., The role of interleukin 2 in autoimmunity, Immunol Today, 10, pp. 246-251, (1989)
[3]  
Kroemer G., Martinez-A C., Cytokines and auloimmune diseases, Clin Immunol Immunopath, 61, pp. 275-295, (1991)
[4]  
Toribio M.L., Gutierrez-Ramos J.C., Pezzi L., Marcos M.A.R., Martinez-A C., Interleukin-2-dependent autocrine proliferation in T-cell development, Nature, 342, pp. 82-85, (1989)
[5]  
Stott D.I., Merino J., Schurmans S., Lambert P.-H., Expression of anti-DNA clonotypes and the role of helper T-lymphocytes during the autoimmune response in mice tolerant to alloantigens, Autoimmunity, 1, pp. 253-266, (1988)
[6]  
Kuntz M.M., Innes J.B., Weksler M.E., The cellular basis of the impaired autologous mixed lymhocyte reaction in patients with systemic lupus erythematosus, J Clin Invest, 63, pp. 151-153, (1979)
[7]  
Linker-Israeli M., Bakke A.C., Kitridou R.C., Gendler S., Gillis S., Horwitz D.A., Defective Production of Interleukin 1 and Interleukin 2 in patients with systemic lupus erythematosus (SLE), J Immunol, 130, pp. 2651-2655, (1983)
[8]  
Murakawa Y., Takada S., Ueda Y., Suzuki N., Hoshino T., Sakane T., Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus, J Immunol, 134, pp. 187-195, (1985)
[9]  
Huang Y.-P., Miescher P.A., Zubler R.H., The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T-cells, J Immunol, 137, pp. 3515-3520, (1986)
[10]  
Altman A., Theofilopoulos A.N., Weiner R., Katz D.H., Dixon F.J., Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin-2, J Exp Med, 154, pp. 791-808, (1981)